Athanor Capital, LP Infinity Pharmaceuticals, Inc. Transaction History

Athanor Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$1.98 - $5.36 $63,662 - $172,340	-32,153 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.05 - $2.77 $33,760 - $89,063	32,153 New	32,153 $68,000
Q4 2019 Feb 14, 2020	SELL	$0.88 - $1.29 $11,632 - $17,052	-13,219 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.03 - $1.75 $87,736 - $149,066	-85,181 Reduced 86.57%	13,219 $14,000
Q2 2019 Aug 13, 2019	BUY	$1.43 - $1.87 $140,712 - $184,008	98,400 New	98,400 $177,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.